P&G's Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of Procter & Gamble (P&G) for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23YoY (% change)Q1FY24QoQ (% change)Q2FY24
Total Income (₹crs.)1,051.629.75862.6333.791,154.12
Expenses (₹crs.)845.822.82656.0532.56869.65
Net Profit (₹crs.)51.3943.5755.3433.3273.78
Margin (%)4.891.516.42-0.026.39

 

REVENUE: 
P&G reported a total income of ₹1,154.12 crores for Q2FY24, which marks a robust increase of 9.75% sequentially. On a quarter-on-quarter basis, the company experienced a substantial surge of 33.79% from Q1FY24.

 

EXPENSES: 
Expenses for P&G in Q2FY24 amounted to ₹869.65 crores, representing a significant increase of 32.56% compared to the preceding quarter. On a year-on-year basis, expenses increased by 2.82%. 

 

NET PROFIT: 
The net profit for P&G in Q2FY24 was ₹73.78 crores, signifying a solid increase of 33.32% compared to Q1FY24. Year-on-year, the company demonstrated impressive growth in net profit, with a substantial increase of 43.57%. This highlights the effectiveness of P&G's strategies and its ability to convert revenue into profit.
 

MARGINS: 
P&G's margin for Q2FY24 was 6.39%, showing a slight decrease of -0.02% compared to the preceding quarter. Year-on-year, the margin improved by 1.51%. The margin, although slightly reduced from the previous quarter, remains healthy and indicates effective cost management.

 

In conclusion, P&G's financial performance in Q2FY24 demonstrates substantial year-on-year and quarter-on-quarter growth. The company's ability to increase total income and net profit while maintaining a healthy margin is a testament to its effective business strategies and market adaptability.

 

Stay tuned for more updates on P&G's financial performance in the future.

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Share Market

blog-logo

10 mins read . 09 Dec 2024

What is the Bombay Stock Exchange?

  • 0 people read
blog-logo

Share Market

blog-logo

13 mins read . 09 Dec 2024

Stocks Under 5 Rupees in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions